Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

East Hanover, New Jersey 07936


Purpose:

Left ventricular hypertrophy (LVH) increases the risk of cardiovascular morbidity and mortality in patients with high blood pressure, compared to those without LVH. Reduction of left ventricular mass (LVM) with antihypertensive agents is associated with improved clinical outcome. This study will evaluate the effects of amlodipine/benazepril in reducing LVM in patients with high risk hypertension.


Criteria:

Inclusion Criteria: - Males or female patients ≥ 55 years of age - LVH as confirmed by echocardiogram - Patients with high risk hypertension, currently treated or already taking antihypertensive medication Exclusion Criteria: - Renal artery stenosis - Symptomatic heart failure or known ejection fraction < 40% - Myocardial infarction or stroke within 6 months - Presence of cranial aneurysm clips, coronary artery metal stents and pacemakers - Pregnant or lactating females - Cancer within the last 5 years


NCT ID:

NCT00139555


Primary Contact:

Study Director
Novartis Pharmaceuticals
Novartis Pharmaceuticals


Backup Contact:

N/A


Location Contact:

East Hanover, New Jersey 07936
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 15, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.